团体元认知疗法改善心脏康复路径中抑郁焦虑心理干预效果:PATHWAY Group MCT随机对照试验研究方案
心脏康复患者焦虑抑郁高发,现有药物和心理治疗对该群体效果有限,且心理干预尚未系统整合进心脏康复服务。本试验为多中心两臂单盲随机对照试验,目标样本332例,比较团体元认知疗法联合常规心脏康复与单独常规心脏康复的临床和成本效果。主要结局为4个月随访时医院焦虑抑郁量表总分。
要点
- 团体元认知疗法针对反刍、担忧和威胁监测的思维风格,可能适合心脏康复患者。
- 试验目标样本332例,在五个英国NHS信托机构招募焦虑和/或抑郁症状升高的心脏康复患者。
- 干预组接受六次每周团体元认知疗法,由心脏康复专业人员或研究护士实施。
核心结论
- 本试验将评估团体元认知疗法对心脏康复患者焦虑抑郁的有效性和成本效果,若有效可能改善该大量患者群体的心理福祉和生活质量。
研究设计与样本
- 多中心、两臂、单盲随机对照试验,比较团体元认知疗法联合常规心脏康复与单独常规心脏康复。
- 目标样本n=332,在五个英国国家医疗服务体系信托机构招募焦虑和/或抑郁症状升高的心脏康复患者。
- 干预组接受六次每周团体元认知疗法,由心脏康复专业人员或研究护士实施;两组均接受所在信托的常规心脏康复项目。
关键数值与推荐
- 主要结局为4个月随访时医院焦虑抑郁量表总分测量的焦虑和抑郁症状严重程度。
- 次要结局包括12个月随访时焦虑/抑郁严重程度、健康相关生活质量、创伤后应激症状严重程度及4个月和12个月随访时元认知信念强度。
- 定性访谈将帮助构建干预效果障碍和促进因素的说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anxiety and depression are prevalent among cardiac rehabilitation patients but pharmacological and psychological treatments have limited effectiveness in this group. Furthermore, psychological interventions have not been systematically integrated into cardiac rehabilitation services despite being a strategic priority for the UK National Health Service. A promising new treatment, metacognitive therapy, may be well-suited to the needs of cardiac rehabilitation patients and has the potential to improve outcomes. It is based on the metacognitive model, which proposes that a thinking style dominated by rumination, worry and threat monitoring maintains emotional distress. Metacognitive therapy is highly effective at reducing this thinking style and alleviating anxiety and depression in mental health settings. This trial aims to evaluate the effectiveness and cost-effectiveness of group-based metacognitive therapy for cardiac rehabilitation patients with elevated anxiety and/or depressive symptoms. METHODS/DESIGN: The PATHWAY Group-MCT trial is a multicentre, two-arm, single-blind, randomised controlled trial comparing the clinical- and cost-effectiveness of group-based metacognitive therapy plus usual cardiac rehabilitation to usual cardiac rehabilitation alone. Cardiac rehabilitation patients (target sample n = 332) with elevated anxiety and/or depressive symptoms will be recruited across five UK National Health Service Trusts. Participants randomised to the intervention arm will receive six weekly sessions of group-based metacognitive therapy delivered by either cardiac rehabilitation professionals or research nurses. The intervention and control groups will both be offered the usual cardiac rehabilitation programme within their Trust. The primary outcome is severity of anxiety and depressive symptoms at 4-month follow-up measured by the Hospital Anxiety and Depression Scale total score. Secondary outcomes are severity of anxiety/depression at 12-month follow-up, health-related quality of life, severity of post-traumatic stress symptoms and strength of metacognitive beliefs at 4- and 12-month follow-up. Qualitative interviews will help to develop an account of barriers and enablers to the effectiveness of the intervention. DISCUSSION: This trial will evaluate the effectiveness and cost-effectiveness of group-based metacognitive therapy in alleviating anxiety and depression in cardiac rehabilitation patients. The therapy, if effective, offers the potential to improve psychological wellbeing and quality of life in this large group of patients. TRIAL REGISTRATION: UK Clinical Trials Gateway, ISRCTN74643496 , Registered on 8 April 2015.
引用
- Wells A, McNicol K, Reeves D, et al. Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial. Trials. 2018. PMID: 29615092. doi:10.1186/s13063-018-2593-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。